SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Celgene-CELG
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
804 71 0 CELG
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
629[Low Dose Thalidomide PII for MMM] >>Journal of Clinical Oncology, Vol 22tuck-2/6/2004
628Clinical Data on REVIMID(TM) in Multiple Myeloma and Myelodysplastic Syndromes Tnigel bates-12/3/2003
627One Hundred and Twenty-Eight Abstracts on Recent Clinical Data for THALOMID(R), nigel bates-12/1/2003
626Celgene Aims For Fast FDA Approval Matthew Herper [Forbes], 07.23.03, 1:20 PM ETsim1-7/23/2003
625Focalin(TM) LA Pivotal Clinical Trial Initiated in Adults With ADD/ADHD Wednesdasim1-7/2/2003
624Doc, the interesting thing about the converts is that the pricing is not based oVector1-6/5/2003
623<i>the terms are ridiculous. 1.75% up 50%!</i> I agree with all thaDoc Bones-6/5/2003
622I wasn't arguing with the terms - they are (very) good. Won't T revenue nigel bates-5/31/2003
621I wish I could hang some 1.75% debt on my personal ballance sheet. In any eventVector1-5/31/2003
620<i>it will hang on their balance shit</i> Miljenko, you get the prijayhawk969-5/31/2003
619NB, T revenue will not be sufficient to fully develop R. Also, they may go shopMiljenko Zuanic-5/30/2003
618Nigel, the terms are ridiculous. 1.75% up 50%! That is free money to go hunting.Vector1-5/30/2003
617Terms are pretty decent from the CELG pov, but I'm slightly puzzled as to whnigel bates-5/30/2003
616I am not CN fun, but this does not looks so bad. Celgene Corporation Announces Miljenko Zuanic-5/29/2003
615>>PARIS, May 15 /PRNewswire-FirstCall/ -- Data presented at the Seventh Intuck-5/15/2003
61408:45 ET CELG Celgene reports Revimid clinical data (29.84) Announces that tom pope-5/15/2003
613Thalidomide May Carry Dementia Risks: Case Report Thu May 1 NEW YORK (Reuters Hnigel bates-5/2/2003
612Celgene Strengthens Broad Intellectual Property Estate for Kinase Program With Unigel bates-4/2/2003
611UK to Begin Thalidomide Trial Against Lung Cancer Mon sim1-1/27/2003
610>>J Clin Oncol 2003 Jan 1;21(1):16-9 Thalidomide alone or with dexamethatuck-1/11/2003
609Deleted due to SI hiccup; see next posttuck-1/11/2003
608ROCKVILLE, Md., Jan. 2 /PRNewswire-FirstCall/ -- EntreMed, Inc. (Nasdaq: ENMD - nigel bates-1/2/2003
607SSB ASH Report ragingbull.lycos.comsim1-12/11/2002
606>>PHILADELPHIA, Dec. 10 /PRNewswire-FirstCall/ -- Celgene Corporation (Nastuck-12/10/2002
605>>PHILADELPHIA, Dec. 9 /PRNewswire-FirstCall/ -- Celgene Corporation (Nasdtuck-12/9/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News